Ascent Group LLC bought a new stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 291 shares of the medical instruments supplier's stock, valued at approximately $344,000.
Other hedge funds have also made changes to their positions in the company. Greenleaf Trust grew its holdings in shares of Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock valued at $1,030,000 after purchasing an additional 10 shares in the last quarter. Brooklyn Investment Group grew its stake in shares of Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after acquiring an additional 10 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in shares of Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares during the period. Albion Financial Group UT raised its stake in shares of Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock valued at $890,000 after acquiring an additional 11 shares in the last quarter. Finally, TD Private Client Wealth LLC boosted its holdings in Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after purchasing an additional 11 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.
Analyst Ratings Changes
A number of research firms have issued reports on MTD. Robert W. Baird increased their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Barclays assumed coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price target for the company. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their target price for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Finally, Evercore ISI decreased their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a report on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.
Check Out Our Latest Stock Analysis on MTD
Mettler-Toledo International Stock Performance
Shares of MTD stock traded up $6.43 during mid-day trading on Wednesday, hitting $1,282.53. 27,275 shares of the stock were exchanged, compared to its average volume of 168,171. The stock's fifty day simple moving average is $1,261.83 and its two-hundred day simple moving average is $1,185.40. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The stock has a market capitalization of $26.42 billion, a price-to-earnings ratio of 32.49, a P/E/G ratio of 3.78 and a beta of 1.37.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. During the same period in the prior year, the firm earned $9.65 EPS. The business's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.
Insider Activity
In related news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 165 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 0.77% of the stock is currently owned by company insiders.
About Mettler-Toledo International
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Read More

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report